Vistin Pharma ASA (LON: 0RAM)

Vistin Pharma ASA Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 14, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	73	80	59	72	66	40
Market Cap Growth	6.31%	35.53%	-18.07%	8.95%	66.93%	32.27%
Enterprise Value	73	80	62	68	58	14
Last Close Price	1.65	1.70	1.12	1.63	1.33	0.80
PE Ratio	16.82	22.66	-	34.56	-	6.97
PS Ratio	2.90	2.36	2.30	3.08	3.05	2.02
PB Ratio	3.98	3.20	2.56	3.12	2.84	1.12
P/TBV Ratio	3.98	3.20	2.56	3.12	2.84	1.12
P/FCF Ratio	22.18	14.21	-	-	-	795.14
P/OCF Ratio	12.39	11.41	-	62.82	-	24.36
EV/Sales Ratio	2.39	2.36	2.43	2.90	2.67	0.70
EV/EBITDA Ratio	10.02	12.18	138.71	18.91	12.49	6.57
EV/EBIT Ratio	12.31	15.08	-	24.33	14.89	9.47
EV/FCF Ratio	18.55	14.23	-	-	-	273.84
Debt / Equity Ratio	0.03	0.01	0.18	0.01	-	0.01
Debt / EBITDA Ratio	0.08	0.04	7.95	0.03	-	0.10
Debt / FCF Ratio	0.15	0.05	-	-	-	4.34
Asset Turnover	1.10	1.08	0.82	0.85	0.61	0.45
Inventory Turnover	1.89	2.16	2.19	2.57	2.62	3.16
Quick Ratio	1.06	1.23	0.62	1.92	3.38	5.03
Current Ratio	2.13	2.43	1.35	3.36	4.39	5.39
Return on Equity (ROE)	20.06%	15.29%	-1.72%	9.07%	-28.27%	17.34%
Return on Assets (ROA)	13.34%	10.58%	-1.03%	6.34%	6.89%	2.09%
Return on Capital (ROIC)	16.57%	13.22%	-1.27%	7.56%	8.27%	2.74%
Earnings Yield	5.95%	4.41%	-0.67%	2.89%	-12.53%	14.35%
FCF Yield	5.40%	7.04%	-10.68%	-2.12%	-25.70%	0.13%
Dividend Yield	4.42%	4.57%	5.64%	3.87%	3.22%	10.68%
Payout Ratio	90.30%	-	-	89.17%	-	-
Buyback Yield / Dilution	-	-	-	-	-25.81%
Total Shareholder Return	4.42%	4.57%	5.64%	3.87%	3.22%	-15.13%

Source: S&P Capital IQ. Standard template. Financial Sources.